comparemela.com
Home
Live Updates
Christinel Espiritu - Breaking News
Pages:
Latest Breaking News On - Christinel espiritu - Page 1 : comparemela.com
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
End-of-treatment data from two Phase 2a combination clinical trials with imdusiran to be presented at the EASL Congress in June 2024 Preliminary data from the single-dose portion of the AB-101-001.
United states
Katie anderson
Ram bhamidimarri
Ronaldg nahass
Deana antoniello
Kosh agarwal
Anita kohli
Jeong heo
Gavin cloherty
Louise bussey
Naim alkhouri
Shariec ganchua
Stuartc gordon
Christinel espiritu
Tatiana burda
Stuart roberts
Arbutus to Present AB-729 and AB-836 Data at EASL Congress
WARMINSTER, Pa., June 07, 2023 (GLOBE NEWSWIRE) Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging.
United states
Fung yuen
N acetylgalactosamine galnac
Lisam caperelli
Christinel espiritu
Securities exchange
Arbutus biopharma corporation nasdaq
World health organization
Biopharma corporation
European association
Abstract number
Looking statements
Securities act
Securities exchange act
Arbutu annual report
Arbutu quarterly reports
vimarsana © 2020. All Rights Reserved.